Document is current

Article History

Received: 12 November 2021

Accepted: 1 March 2022

First Online: 6 April 2022

Declarations

:

: L Peyrin-Biroulet reports personal fees from Galapagos, AbbVie, Janssen, Genentech, Ferring, Tillots, Celltrion, Takeda, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Inotrem, Allergan, MSD, Roche, Arena, Gilead, Amgen, BMS, Vifor, Norgine, Mylan, Lilly, Fresenius Kabi, OSE Immunotherapeutics, Enthera, Theravance, Pandion Therapeutics, Gossamer Bio, Viatris, and Thermo Fisher; -Grants from Abbvie, MSD, Takeda, and Fresenius Kabi; and stock options from CTMA. G Bouguen received lecture fees from Abbvie, Ferring, MSD, Takeda, and Pfizer and consultant fees from Takeda and Janssen. D Laharie declares counseling, boards, transports or fees from Abbvie, Biogaran, Biogen, Ferring, HAC Pharma, Janssen, MSD, Novartis, Pfizer, Prometheus, Roche, Takeda, Theradiag and Tillots. G Savoye has received lecture fees from Vifor Pharma, Takeda, Pfizer, HAC Pharma, Abbvie, MSD, and Ferring France. This author has also received travel accommodations from Ferring, Abbvie, and MSD France as well as a research grant from Ferring. C Giletta has received lecture/consulting fees from Abbvie, Takeda, Pfizer, Celltrion, and Janssen. C Michiels received lecture fees from MSD and Abbvie and invitations to congresses form MSD, Abbvie and Ferring. M Fumery received lecture and consultant fees form Abbvie, MSD, Takeda, Janssen, Celgene, Boehringer, Biogen, Amgen, Celltrion, Pfizer, Galapagos and Lilly. A. Buisson disclosed consulting fees for Abbvie, Amgen, Arena, Biogen, Celltrion, CTMA, Ferring, Janssen, MSD, Nexbiome, Pfizer, Roche, Takeda, and Tillots, as well as lecture fees for Abbvie, Amgen, Biogen, Janssen, Mayoly-Spindler, MSD, Norgine Pfizer, Roche, Takeda, Tillots, and Vifor Pharma. P. Cacoub received consultancies and honoraria from Vifor Pharma.